EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer

Thomanai Lamtha iD, Nathjanan Jongkon, Tossaporn Lertvanithphol, Mati Horprathum iD, Supaphorn Seetaha, Kiattawee Choowongkomon iD

ACS Omega · 18.02.2025 · 10 (6) · 6191-6200

DOI: 10.1021/acsomega.4c11108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 08.02.2025. Verfasst von Thomanai Lamtha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Protein Engineering and Bioinformatics (PROTEP), Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, T…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kasetsart University Research and Development Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Laboratory of Protein Engineering and Bioinformatics (PROTEP), Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
  • Department of Clinical Chemistry, Faculty of Medical Technology, Nation University, Lampang 52000, Thailand.
  • Department of Social and Applied Science, College of Industrial Technology, King Mongkut's University of Technology North Bangkok, Bangkok 10800, Thailand.
  • The National Electronics and Computer Technology Center (NECTEC), National Science and Technology Development Agency (NSTDA), Thailand Science Park, Pathum Thani 12120, Thailand.

ORCID-Profile: Thomanai Lamtha, Mati Horprathum, Kiattawee Choowongkomon

Förderung

  • Kasetsart University Research and Development Institute

Zitieren

APA

Lamtha, T., Jongkon, N., Lertvanithphol, T., Horprathum, M., Seetaha, S., & Choowongkomon, K. (2025). Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer. ACS Omega, 10(6), 6191-6200. https://doi.org/10.1021/acsomega.4c11108

Vancouver

Lamtha T, Jongkon N, Lertvanithphol T, Horprathum M, Seetaha S, Choowongkomon K. Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer. ACS Omega. 2025;10(6):6191-6200. doi:10.1021/acsomega.4c11108

BibTeX
@article{Lamtha2025,
  author = {Lamtha, Thomanai and Jongkon, Nathjanan and Lertvanithphol, Tossaporn and Horprathum, Mati and Seetaha, Supaphorn and Choowongkomon, Kiattawee},
  title = {Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer},
  journal = {ACS Omega},
  year = {2025},
  volume = {10},
  number = {6},
  pages = {6191--6200},
  doi = {10.1021/acsomega.4c11108}
}
Kostenlos starten →